Metraipolis › archive › dc_dd47bd3c9983

Phosphatidylinositol 3-kinase and mechanistic target of rapamycin dualinhibitor, VDC597, as a therapeutic agent for canine osteosarcoma — Europe PMC PMID:41106249

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41106249
DOI
10.1016/j.jpet.2025.103715
License (as archived)
solo-consultazione
Archived
2026-11-09T21:52:19.997Z
SHA-256 of the archived text
689137980865966f51e4b6527165bbee850b7c3b6ff642f455af7f9351876fd8
Stable URL of this page
https://metraipolis.com/documento/dc_dd47bd3c9983

How to cite

Phosphatidylinositol 3-kinase and mechanistic target of rapamycin dualinhibitor, VDC597, as a therapeutic agent for canine osteosarcoma — Europe PMC PMID:41106249 — Europe PMC (en), https://europepmc.org/article/MED/41106249 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dd47bd3c9983 (Metraipolis archive dc_dd47bd3c9983, sha256 689137980865966f51e4b6527165bbee850b7c3b6ff642f455af7f9351876fd8)
BibTeX
@misc{dcdd47bd3c9983,
  title = {Phosphatidylinositol 3-kinase and mechanistic target of rapamycin dualinhibitor, VDC597, as a therapeutic agent for canine osteosarcoma — Europe PMC PMID:41106249},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41106249},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dd47bd3c9983; sha256 689137980865966f51e4b6527165bbee850b7c3b6ff642f455af7f9351876fd8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41106249. Agents can read the archived copy with the MCP tool read_document.